James Whyte
UK Bar Guide 2025
Band 1 : Intellectual Property
Email address
[email protected]Contact number
020 7405 4321Share profile
Band 1
About
Provided by James Whyte
Practice Areas
Barrister specialising in intellectual property law, with a particular emphasis on technically complex patent cases in biotechnology and pharmaceuticals. Scheduled trials include DSM v Mara (algal fatty acids), Hill v Touchlight (DNA production), Abbott v Dexcom - Trial E (glucose sensors), Samsung BioEpis v Alexion (antibody), Accord v Hoffmann-La Roche (subcutaneous formulation). Recent cases include Abbott v Dexcom - Trial C, Gilead v NuCana (nucleoside derivatives), InterDigital v Lenovo (telecoms), Optis v Apple (telecoms), Insulet v Roche (insulin pumps), Royalty Pharma v Boehringer Ingelheim (royalty dispute under German law), GSK v Fibrogen (iron deficiency drugs; settled shortly before trial), Conversant v Huawei (telecoms), Illumina v Ariosa (cell-free foetal DNA enrichment), Silence v Alnylam (RNAi; settled shortly before trial), Pacific Biosciences v Oxford Nanopore (DNA sequencing; settled shortly before trial), Illumina v Premaitha (prenatal diagnosis), Regeneron v Kymab (antibody engineering).
Career
Educated at Trinity College, Cambridge (top 1st in genetics; PhD in molecular biology); City University (distinction in postgraduate diploma in law); BPP (outstanding in bar vocational course). Called 2005, Lincoln's Inn.
Professional Memberships
Chancery Bar Association, IP Bar Association.
Publications
Co-author of Laddie, Prescott and Vitoria on the Modern Law of Copyright (6th edition forthcoming).